These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 6701301)
21. [Adverse reactions and intracranial contrast medium after myelography]. Fujii K; Hashimoto T; Isaza M; Hashimoto T; Hirabuki N; Miura T; Mitomo M; Kozuka T; Kawai R Rinsho Hoshasen; 1989 Mar; 34(3):323-7. PubMed ID: 2739082 [TBL] [Abstract][Full Text] [Related]
22. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs. Puglisi TA; Green RW; Hall CL; Read WK; Green RA; Tangner CH; Mann FA; Hobson HP Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068 [TBL] [Abstract][Full Text] [Related]
23. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis. Sovak M; Ranganathan R; Kerber CW; Bickford R; Alksne JF AJNR Am J Neuroradiol; 1983; 4(3):319-22. PubMed ID: 6410733 [TBL] [Abstract][Full Text] [Related]
24. Experimental study of arachnoiditis from iohexol, an investigational nonionic aqueous contrast medium. Haughton VM; Ho KC; Lipman BT AJNR Am J Neuroradiol; 1982; 3(4):375-7. PubMed ID: 6810669 [TBL] [Abstract][Full Text] [Related]
25. Cervical myelography using iohexol (Omnipaque), a new contrast medium. Batty VB Clin Radiol; 1984 Jan; 35(1):75-7. PubMed ID: 6690186 [TBL] [Abstract][Full Text] [Related]
28. Cerebral angiography with iohexol. A comparison with metrizamide in man. Holtås S; Cronqvist S; Renaa T Neuroradiology; 1983; 24(4):201-4. PubMed ID: 6338414 [TBL] [Abstract][Full Text] [Related]
29. Metrizamide compared with iohexol for cervical myelography: a double-blind study. Reisin R; Ethier R; de la Sayette V; Melanson D; Eng F Can Assoc Radiol J; 1988 Jun; 39(2):107-10. PubMed ID: 2967830 [TBL] [Abstract][Full Text] [Related]
30. Pain and hemodynamic effects in aortofemoral angiography. Clinical comparison of iohexol, ioxaglate and metrizamide. Nyman U; Nilsson P; Westergren A Acta Radiol Diagn (Stockh); 1982; 23(4):389-99. PubMed ID: 7158401 [TBL] [Abstract][Full Text] [Related]
31. Iohexol and metrizamide for urography in infants and children. Stake G; Smevik B Acta Radiol Suppl; 1983; 366():39-41. PubMed ID: 6591739 [TBL] [Abstract][Full Text] [Related]
32. Clinical trial of iohexol for lumbar myelography. Kendall B; Schneidau A; Stevens J; Harrison M Br J Radiol; 1983 Aug; 56(668):539-42. PubMed ID: 6347311 [TBL] [Abstract][Full Text] [Related]
33. Iohexol in patients with previous adverse reactions to contrast media. Holtås S Invest Radiol; 1984; 19(6):563-5. PubMed ID: 6511264 [TBL] [Abstract][Full Text] [Related]
34. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States. Goldstein HA; Pfennig D Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():167-70. PubMed ID: 2568788 [TBL] [Abstract][Full Text] [Related]
37. Myelography with iohexol (Omnipaque): review of 300 cases. Burrows EH AJNR Am J Neuroradiol; 1985; 6(3):349-51. PubMed ID: 3923792 [TBL] [Abstract][Full Text] [Related]
38. Iohexol: a new nonionic contrast medium for myelography and cisternography with markedly reduced neurotoxicity. Gonsette RE; Liesenborghs L Invest Radiol; 1985; 20(1 Suppl):S32-6. PubMed ID: 3871751 [TBL] [Abstract][Full Text] [Related]
39. Neurotoxicity of iohexol: a new nonionic contrast medium. Bryan RN; Centeno RS; Hershkowitz N; Poelstra RJ; Osato MS Radiology; 1982 Nov; 145(2):379-82. PubMed ID: 7134441 [TBL] [Abstract][Full Text] [Related]